USANA Health Sciences (NYSE:USNA) Trading Down 7.2% - Here's Why

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report)'s stock price was down 7.2% on Thursday . The stock traded as low as $32.83 and last traded at $32.87. Approximately 34,050 shares were traded during mid-day trading, a decline of 82% from the average daily volume of 184,627 shares. The stock had previously closed at $35.43.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd.

USANA Health Sciences Price Performance

The stock has a market cap of $586.03 million, a PE ratio of 17.49, a price-to-earnings-growth ratio of 1.02 and a beta of 0.64. The stock has a 50-day moving average price of $30.89 and a two-hundred day moving average price of $30.02.

USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The company reported $0.74 earnings per share for the quarter, beating analysts' consensus estimates of $0.54 by $0.20. The firm had revenue of $235.85 million during the quarter, compared to analyst estimates of $225.20 million. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. Equities research analysts expect that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Insiders Place Their Bets

In related news, CFO G Doug Iiekking sold 4,548 shares of the stock in a transaction that occurred on Friday, May 9th. The shares were sold at an average price of $29.61, for a total transaction of $134,666.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Walter Noot sold 6,291 shares of the stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $30.29, for a total transaction of $190,554.39. The disclosure for this sale can be found here. Insiders have sold a total of 12,013 shares of company stock valued at $360,149 over the last 90 days. 0.63% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On USANA Health Sciences

A number of institutional investors have recently bought and sold shares of the business. Quantbot Technologies LP purchased a new position in shares of USANA Health Sciences during the 4th quarter valued at approximately $132,000. American Century Companies Inc. increased its stake in shares of USANA Health Sciences by 12.3% in the 4th quarter. American Century Companies Inc. now owns 233,797 shares of the company's stock valued at $8,391,000 after purchasing an additional 25,522 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new stake in shares of USANA Health Sciences in the fourth quarter valued at approximately $83,000. Norges Bank purchased a new stake in USANA Health Sciences in the 4th quarter worth $953,000. Finally, Meeder Asset Management Inc. acquired a new stake in USANA Health Sciences in the 4th quarter valued at about $143,000. 54.25% of the stock is owned by hedge funds and other institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.